Align Technology (ALGN)

Nasdaq Health Care Health Care Supplies S&P 500
$166.00
+6.63 (+4.16%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Trailing 12-month EPS
$6.86
Diluted, last four reported quarters

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Oct 28, 2026Sep/2026$2.32$2.37+2.2%

Our record of ALGN's reports since we began tracking; it grows each quarter.

Latest results, in brief

All ALGN 8-K briefs →
Oct 28, 4:02 PM ET

Align Technology Q3 revenue rises 1.9% to $1.015 billion; GAAP EPS $1.90 vs $0.78

Positive earnings 2.02

Align Technology reported third-quarter 2026 results for the period ended September 30, 2026, with total revenue of $1.015 billion, up 1.9% from a year earlier, and GAAP diluted earnings of $1.90 per share, compared with $0.78 a year earlier. The company also gave fourth-quarter and full-year 2026 revenue ranges and said it expects to repurchase up to $300 million of stock in the fourth quarter.

  • Q3 2026 net revenues were $1,014.8 million, up 1.9% year over year; Clear Aligner revenue rose 4.2% to $839.3 million
  • Q3 2026 GAAP net income was $135.0 million, or $1.90 per diluted share, versus $0.78 in Q3 2025; non-GAAP diluted EPS was $2.80 versus $2.61
  • Q4 2026 revenue is expected to be $1,000 million to $1,020 million; full-year 2026 revenue is expected to be $4,110 million to $4,130 million
  • Company expects to repurchase about $500 million of its common stock in 2026, with up to $300 million planned for Q4; $630.0 million remained under the $1.0 billion program as of September 30, 2026
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$1.01B+1.9% $1.90+143.6% $135.04M13.3%
Jun 2026$1.06B+4.3% $1.51-12.2% $108.29M10.3%
Mar 2026$1.04B+6.2% $1.57+23.6% $112.77M10.8%
Dec 2025$1.05B+5.3% $1.88+35.3% $135.76M13.0%
Sep 2025$995.69M+1.8% $0.78-49.7% $56.75M5.7%
Jun 2025$1.01B-1.6% $1.72+34.4% $124.61M12.3%
Mar 2025$979.26M-1.8% $1.27-8.6% $93.23M9.5%
Dec 2024$995.22M+4.0% $1.39-14.7% $103.81M10.4%

From Align Technology's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$4.03B+0.9% $5.65+0.5%10.2%
FY2024$4.00B+3.5% $5.62-3.3%10.5%
FY2023$3.86B+3.4% $5.81+26.0%11.5%
FY2022$3.73B-5.5% $4.61-52.4%9.7%
FY2021$3.95B+59.9% $9.69-56.8%19.5%

Frequently asked questions

When is Align Technology's next earnings date?

Align Technology has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Align Technology earn last quarter?

For the quarter ended Sep 2026, Align Technology reported diluted EPS of $1.90 (+143.6% year over year) on revenue of $1.01B (+1.9%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.